LMZ plans to sell shares of Fangkai company and paper products company

On the evening of November 12, LMZ (600249) announced that the company plans to transfer 80% of the equity of Liuzhou LMZ Real Estate Development Co., Ltd. (hereinafter referred to as "real estate development company"), 84.62% of the equity of Liuzhou LMZ Paper Co., Ltd. (hereinafter referred to as "paper company"), as well as the equity of real estate development company, paper company and LMZ Paper Industry Co., Ltd Creditor's rights of the company (hereinafter referred to as "paper company"). According to the announcement, LMZ is planning the sale of the above-mentioned major assets. After the completion of the transaction, LMZ no longer holds the equity of Fangkai company and paper company, and no longer enjoys the creditor's rights to Fangkai company, paper company and paper company. LMZ said that the transaction party is the company's largest shareholder, Guangxi Liuzhou Industrial Investment and Development Group Co., Ltd. This transaction will constitute a connected transaction. According to the data as of June 30, 2019, the book value of the creditor's rights of LMZ holding paper products company, paper industry company and real estate development company totaled about 1.17 billion yuan (Unaudited). Liangpin added that this transaction is still in the planning stage, and necessary internal and external decision-making and approval procedures need to be performed, and there is uncertainty in this transaction.
2026-09-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
“Freight Fee Warfare”: The U.S. Imposes Port Charges on Chinese-Linked Vessels — A Shipping Clash Unfolds
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
ARLANXEO Launches State-of-the-Art HNBR Plant in Changzhou, Strengthening Asia-Pacific Supply
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
Recommend Reading
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
China, U.S. and Australia Escalate Antidumping Scrutiny: Chemical Exports Face Rising Compliance Pressure
-
Asia’s Plastics Chain Faces a Shock: Tight Naphtha Supply Drives Up Polymer Costs
-
German Chemical Sentiment Hits a Three-Year Low: Supply Disruption Amplifies Pressure on European Manufacturing
-
March Ethylene Oxide Prices Soar to a Four-Year High in China
-
Post-Holiday Acetic Acid Ethyl Ester Market Rises Strongly (10.8-10.14)
-
March Acetic Acid Market Strongly Rises in China
-
MTBE Market Trend in China Shows Weak Consolidation
-
China's Phenol Market Shows Little Volatility